Anti-arthritis drug Tocilizumab has already seemingly cured a raft of Covid-19 patients in China and Italy, and it has been promoted by a doctor alongside high-dose melatonin
A coronavirus wonder drug and hormone could shield the body from Covid-19, new research has claimed.
Anti-arthritis drug Tocilizumab has already seemingly cured a raft of Covid-19 patients in China and Italy.
More research has now promoted it, it along with high-dose melatonin.
The Manila Doctors Hospital in the Philippines is reportedly the first in the world to experiment with melatonin on high-risk coronavirus patients.
Dr Rafael Castillo writes on Lifestyle.Inq: “Several of the patients we gave high-dose melatonin to already had adult respiratory distress syndrome.
“By God’s grace, they all survived. One of the young cardiologists we’re mentoring texted me the good news about her father, a prominent physician in one of the teaching universities in the country, who has just been discharged after battling COVID-19.
“He was already about to be intubated and hooked to a breathing machine because all drugs given him didn’t seem to work and his pneumonia was getting worse.
“After three days on high-dose melatonin, he turned around, and nine days later, he was sent home.
Intubation is the process of inserting a tube into a patient’s airway in order to enable ventilation.
The doctors are reporting their trial in a scientific journal to aid in the fight against the coronavirus.
Dr Castillo added: “Tocilizumab and high-dose melatonin do the same.
“They’re not viricidal so they can’t kill the virus, but they protect all the organs of the body especially the lungs from the lethal effects of COVID-19.”
Tocilizumab is also referred to as Actemra and produced by the Swiss pharmaceutical firm Roche.
During a groundbreaking study in China in February, it reportedly helped 90% of coronavirus patients recover.
Hospitals in Italy have also enjoyed success with the drug, with dozens of patients witnessing improvements and some even being discharged.